Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Exp Hematol. 2012 Aug 10;40(12):974–982.e1. doi: 10.1016/j.exphem.2012.08.002

Figure 3.

Figure 3

Clinical outcomes stratified by Treg tissue-homing subsets. Probabilities of (A) overall survival, (B) disease-free survival, and (C) non-relapse mortality based on high CLA+ or high α4β7+ Tregs (n = 43) vs low CLA+ and low α4β7+ Tregs (n = 31). High CLA+ Tregs: CLA+ Tregs/Tregs ≥3.25%; High α4β7+ Tregs: α4β7+ Tregs/Tregs ≥21.8%.